For an emerging biopharma company seeking further growth, establishing a presence in Europe is usually an obvious next step. However, going to Europe is a major undertaking. Even though most of Europe shares a common regulatory body, there are many differences to navigate. The cultures, languages, reimbursement approaches, market environments, and decision-making processes vary widely across markets. It’s complicated.
In this paper, Blue Matter introduces seven keys to success in Europe, briefly describing why each is important. Companies should focus on these keys if they’re considering European market entry, are in the process of entering, or if they’ve recently entered and are working to strengthen their presence.
This paper is the first in our “Pathfinder” series. It sets the stage for a multiple papers providing details on each of the seven keys to success. Pathfinder is a range of services Blue Matter offers to help biopharma companies successfully enter European markets.
